AgeneBio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

AgeneBio Inc (AgeneBio) is a pharmaceutical company that develops therapies for psychiatric and neurological diseases. The companys therapy is targeted to prevent neurodegeneration and preserve and restore cognitive function for unserved patients. Its lead candidate AGB101 is under phase 3 of clinical trials for the treatment of mild cognitive impairment (aMCI) and can delay progression to Alzheimers dementia and can target hippocampus overactivity. AgeneBios other pipeline product is GABAA alpha5 a small molecule program is being developed for the treatment of aMCI, autism and schizophrenia, among others. The company partners with Johns Hopkins University and leading research centers worldwide. AgeneBio is headquartered in Baltimore, Maryland, the US.

AgeneBio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AgeneBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AgeneBio Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AgeneBio Raises USD0.5 Million in Venture Financing 10
AgeneBio Raises USD4 Million in Venture Financing 11
AgeneBio Raises US$1 Million In Venture Financing 12
AgeneBio Raises US$1 Million In Venture Financing 13
AgeneBio Raises US$0.4 Million In Venture Financing 14
AgeneBio Inc - Key Competitors 15
AgeneBio Inc - Key Employees 16
AgeneBio Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Jan 08, 2018: $1.8 Million in New Funding Supports Clinical Stage Treatments 18
May 15, 2017: $2.6 Million in New Grants Spurs Innovation 20
Product News 23
06/30/2017: AgeneBio Receives Grant from Alzheimers Drug Discovery Foundation for Drug-Discovery Program to Delay the Onset of Alzheimers Dementia 23
Clinical Trials 24
Sep 19, 2017: AgeneBio Receives NIH Grant to Initiate Phase 3 HOPE4MCI Trial to Treat MCI Due to Alzheimers Disease 24
Sep 13, 2017: AgeneBio to Receive up to $10 Million in NIH Funding to Advance Program for Mild Cognitive Impairment Due to Alzheimers Disease 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List Of Tables


AgeneBio Inc, Pharmaceuticals & Healthcare, Key Facts 2
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AgeneBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AgeneBio Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AgeneBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AgeneBio Raises USD0.5 Million in Venture Financing 10
AgeneBio Raises USD4 Million in Venture Financing 11
AgeneBio Raises US$1 Million In Venture Financing 12
AgeneBio Raises US$1 Million In Venture Financing 13
AgeneBio Raises US$0.4 Million In Venture Financing 14
AgeneBio Inc, Key Competitors 15
AgeneBio Inc, Key Employees 16

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

AgeneBio Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

AgeneBio Inc (AgeneBio) is a pharmaceutical company that develops therapies for psychiatric and neurological diseases. The companys therapy is targeted to prevent neurodegeneration and preserve and restore cognitive function for

USD 250 View Report

AgeneBio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

AgeneBio Inc (AgeneBio) is a pharmaceutical company that develops therapies for neurological and psychiatric diseases. The companys therapy is targeted to prevent neurodegeneration and preserve and restore cognitive function for

USD 250 View Report

Spectrum Brands Holdings Inc - Strategic SWOT Analysis Review

Spectrum Brands Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

STR Holdings Inc - Strategic SWOT Analysis Review

STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available